Evidence map›Paper›PMID 38179314›Full record

ArticleOne health (Amsterdam, Netherlands)2024

Prevalence and drug susceptibility of clinical

Bac V G Nguyen, Hau H N Nguyen, Thanh-Hoa Vo, Minh-Tri Le, Viet-Khoa Tran-Nguyen, Thao Thanh Vu, Phuoc-Vinh Nguyen

Open access · goldAbstract read
In one paragraph

Article in One health (Amsterdam, Netherlands), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. EnhancedDrug delivery · 2025
    Article
  5. Review
  6. Microorganisms · 2025
    Review
  7. Evaluation of Fifteen 5,6-Dihydrotetrazolo[1,5-Journal of fungi (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Biofilm formation and drug susceptibility of biofilmIranian journal of microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Bac V G NguyenFaculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam.
Hau H N NguyenFaculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam.
Thanh-Hoa VoSchool of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Viet Nam.
Minh-Tri LeSchool of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Viet Nam.
Viet-Khoa Tran-NguyenCentre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, Marseille, France.
Thao Thanh VuFaculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam.
Phuoc-Vinh NguyenSchool of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Viet Nam.
Ho Chi Minh City Medicine and Pharmacy University · VNVietnam National University Ho Chi Minh City · VNCentre de Recherche en Cancérologie de Marseille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the nature,

Indexed as

Antifungal agentsCandida speciesDrug-resistance susceptibilityERG11

Identifiers

PMID38179314
PMCPMC10761778
OpenAlexW4389285321

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.